Pancreatic Cancer Research

ResearcherCharles UniversityNo recent work listed

Radoslav Matěj

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6152-6343; OpenAlex author ID A5009344355. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic can… Co-author DOI 10.4149/neo_2023_230721n380↗
  2. Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 20… Last author DOI 10.1002/path.4498↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Blanka Rosová · 1 shared paper, 2023 · strength 0.17
  2. Árpád Szabó · 1 shared paper, 2023 · strength 0.17
  3. Josef Dvořák · 1 shared paper, 2023 · strength 0.17
  4. Bohuslav Melichar · 1 shared paper, 2023 · strength 0.17
  5. Zdeněk Rohan · 1 shared paper, 2015 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.